Methods for effecting neuroprotection
CA 2403555 A1 · Owner: Queen'S University At Kingston · Inventors: Bains, Jaideep S.; Ferguson, Alastair V.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention relates to methods for preventing damage to excitable cells following ischemic by administering to a patient who is undergoing or who has undergone an ischemic event an effective amount of a compound which increases a transient potassium (K+) conductance in the excitable cells of the patient. The present invention also provides a method for screening for compounds which increase a transient K+ current in the excitable cells of a patient.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed March 27, 2001. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended March 27, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by March 27, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.